Evercore Breaks Down Regeneron's Q2 Report

By: via Benzinga
Shares of Regeneron Pharmaceuticals Inc (NASDAQ: REGN) wereup more than 5 percent on Tuesday after the company reported ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.